MICROPEROXIDASE (MP-11) SODIUM SALT(104870-94-2)
- Name: MICROPEROXIDASE (MP-11) SODIUM SALT
- Synonyms:Ferrate(4-),[L-valyl-L-glutaminyl-L-lysyl-L-cysteinyl-L-alanyl-L-glutaminyl-L-cysteinyl-L-histidyl-L-threonyl-L-valyl-L-glutamicacid cyclic (4®12'),(7®7')-bis(sulfide) with7,12-bis(1-mercaptoethyl)-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(6-)-N21,N22,N23,N24]-,tetrasodium; 22H-30,33-Imino-2,21:20,23-dimetheno-25,28-nitrilopyrrolo[2,3-e1][1,14,4,7,10,18]dithiatetraazacyclotritriacontine,cyclic peptide deriv., iron complex;22H-30,33-Imino-2,21:20,23-dimetheno-25,28-nitrilopyrrolo[2,3-e1][1,14,4,7,10,18]dithiatetraazacyclotritriacontine,ferrate(4-) deriv.; L-Glutamic acid, L-valyl-L-glutaminyl-L-lysyl-L-cysteinyl-L-alanyl-L-glutaminyl-L-cysteinyl-L-histidyl-L-threonyl-L-valyl-,cyclic (4®12'),(7®7')-bis(sulfide) with7,12-bis(1-mercaptoethyl)-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoicacid, iron complex; Microperoxidase MP 11 sodium salt
- Molecular Formula:C84H112 Fe N20 O21 S2 . 4 Na
- Molecular Weight:1973.96
- CAS Registry Number:104870-94-2
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 104892-75-3/Methanediamine, N,N,N-trimethyl-N-nitro- (9CI)
- 104892-72-0/1-Propanamine,N,N-dimethyl-2-nitro-(9CI)
- 104886-23-9/Furo[3,2-b]pyridine,2,3-dihydro-3-(1-methylethyl)-(9CI)
- 104880-95-7/(R)-2-Amino-3-(4-fluorophenyl)propionicacidethylester
- 104874-86-4/Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]-, (S)-
- 104874-26-2/4-HYDROXYBENZOIC ACID-RING-UL-14C
- 104874-25-1/MENTHOLGLUCURONIC ACID AMMONIUM SALT
- 104873-98-5/(3S)-3-METHYL-1,4-BENZODIAZEPINE-2,5-DIONE
- 104872-95-9/4-AMINOBENZOIC ACID, [14C(U)]
- 104872-94-8/D-MANNOSE 6-PHOSPHATE BARIUM SALT
- 104872-92-6/4-NITROPHENYL-BETA-D-MELIBIOSIDE
- 104872-91-5/MICROPEROXIDASE (MP-9) AMMONIUM SALT
- 104870-94-2/MICROPEROXIDASE (MP-11) SODIUM SALT
- 104869-26-3/NF 157
- 104863-72-1/Ethanone, 1-(1,3-dithian-2-yl)-2,2,2-trifluoro- (9CI)
- 104863-49-2/2-Thiazolemethanol, alpha-methyl-, (alphaS)- (9CI)
- 104860-32-4/1-Piperidinecarboxylicacid,4-amino-3-methoxy-,ethylester,trans-(9CI)
- 104860-26-6/CIS-1-[3-(4-FLUOROPHENOXY)PROPYL]-3-METHOXY-4-PIPERIDYLAMINE
- 104857-68-3/Methyl 15-[(trimethylsilyl)oxy]abieta-8,11,13-trien-18-oate
- 104851-39-0/1H-Indene,2,3-dihydro-5-(1-methylethyl)-(9CI)
- 104846-62-0/tert-Butyl-dimethyl-(4-methylene-3-{2-[7a-methyl-1-(1,4,5-trimethyl-hex-2-enyl)-octahydro-inden-4-ylidene]-ethylidene}-cyclohexyloxy)-silane
- 104845-82-1/O,Oμ-Diaminopropane-1,3-diol dihydrochloride
- 104842-73-1/3-Pyridinecarboxaldehyde,2-(1-piperazinyl)-(9CI)
- 104841-30-7/Bryostatin B
- 104841-29-4/Bryostatin A
- 104840-48-4/Morpholine, 4-(3-methyl-3-butenyl)- (9CI)
- 104835-70-3/ALPHA,BETA-METHYLENEADENOSINE 5'-DIPHOSPHATE SODIUM SALT
- 104873-01-0/2,4,5-TRICHLOROPHENOXY-ACETIC ACID-RING-UL-14C
- 104877-13-6/2-Naphthalenecarboxylicacid,3-amino-5,6,7,8-tetrahydro-(9CI)
- 104885-49-6/2(1H)-Pyridinone,5-ethyl-4-hydroxy-(9CI)
